# Bridger Aerospace Group Holdings, Inc.: financial statements, quarterly

BAER · Nasdaq · CIK 1941536 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/baer.md) · [Financials](/companies/baer/financials.md) · [Filings](/companies/baer/filings.md) · [Insiders](/companies/baer/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/baer/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [53.6](/filings/0001628280-24-047665.md) | [1.1 d](/filings/0001628280-25-012821.md) | [5.5](/filings/0001628280-25-024290.md) | [13.0](/filings/0001941536-25-000006.md) | [64.5](/filings/0001941536-25-000011.md) | [15.6 d](/filings/0001941536-26-000005.md) | [15.6](/filings/0001941536-26-000010.md) | [30.8](/filings/0001941536-26-000025.md) | [67.9](/filings/0001941536-25-000011.md) | [8.5 d](/filings/0001941536-26-000005.md) | [8.5](/filings/0001941536-26-000010.md) | [30.5](/filings/0001941536-26-000025.md) |
| Cost of revenue | $m | [16.0](/filings/0001628280-24-047665.md) | [7.6 d](/filings/0001628280-25-012821.md) | [9.2](/filings/0001628280-25-024290.md) | [9.9](/filings/0001941536-25-000006.md) | [23.0](/filings/0001941536-25-000011.md) | [15.4 d](/filings/0001941536-26-000005.md) | [17.2](/filings/0001941536-26-000010.md) | [18.7](/filings/0001941536-26-000025.md) | [21.1](/filings/0001941536-25-000011.md) | [14.1 d](/filings/0001941536-26-000005.md) | [17.0](/filings/0001941536-26-000010.md) | [19.2](/filings/0001941536-26-000025.md) |
| Gross profit | $m | [37.6](/filings/0001628280-24-047665.md) | [(6.5) d](/filings/0001628280-25-012821.md) | [(3.7)](/filings/0001628280-25-024290.md) | [3.1](/filings/0001941536-25-000006.md) | [41.5](/filings/0001941536-25-000011.md) | [0.2 d](/filings/0001941536-26-000005.md) | [(1.6)](/filings/0001941536-26-000010.md) | [12.1](/filings/0001941536-26-000025.md) | [46.8](/filings/0001941536-25-000011.md) | [(5.6) d](/filings/0001941536-26-000005.md) | [(8.5)](/filings/0001941536-26-000010.md) | [11.3](/filings/0001941536-26-000025.md) |
| Selling, general and administrative | $m | [15.1](/filings/0001628280-24-047665.md) | [19.4 d](/filings/0001628280-25-012821.md) | [11.6](/filings/0001628280-25-024290.md) | [7.9](/filings/0001941536-25-000006.md) | [8.6](/filings/0001941536-25-000011.md) | [7.7 d](/filings/0001941536-26-000005.md) | [8.6](/filings/0001941536-26-000010.md) | [6.5](/filings/0001941536-26-000025.md) | [7.7](/filings/0001941536-25-000011.md) | [13.4 d](/filings/0001941536-26-000005.md) | [16.7](/filings/0001941536-26-000010.md) | [5.3](/filings/0001941536-26-000025.md) |
| Operating income | $m | [22.6](/filings/0001628280-24-047665.md) | [(25.9) d](/filings/0001628280-25-012821.md) | [(15.3)](/filings/0001628280-25-024290.md) | [(4.8)](/filings/0001941536-25-000006.md) | [32.9](/filings/0001941536-25-000011.md) | [(7.5) d](/filings/0001628280-25-012821.md) | [(10.2)](/filings/0001628280-25-024290.md) | [5.5](/filings/0001941536-25-000006.md) | [39.0](/filings/0001941536-25-000011.md) | not reported | not reported | not reported |
| Interest expense | $m | [6.0](/filings/0001628280-24-031786.md) | [6.0 d](/filings/0001628280-24-031786.md) | [5.9](/filings/0001628280-24-031789.md) | [5.9](/filings/0001628280-24-036974.md) | [6.0](/filings/0001628280-24-047665.md) | [5.9 d](/filings/0001628280-25-012821.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.3)](/filings/0001628280-24-047665.md) | [0.0 d](/filings/0001628280-25-012821.md) | [0.0](/filings/0001628280-25-024290.md) | [(0.5)](/filings/0001941536-25-000006.md) | [0.0](/filings/0001941536-25-000011.md) | [(0.3) d](/filings/0001941536-26-000005.md) | [0.3](/filings/0001941536-26-000010.md) | [0.2](/filings/0001941536-26-000025.md) | [(0.8)](/filings/0001941536-25-000011.md) | [0.2 d](/filings/0001941536-26-000005.md) | [0.0](/filings/0001941536-26-000010.md) | [(0.0)](/filings/0001941536-26-000025.md) |
| Net income | $m | [17.5](/filings/0001628280-24-047665.md) | [(31.1) d](/filings/0001628280-25-012821.md) | [(20.1)](/filings/0001941536-25-000011.md) | [(10.0)](/filings/0001941536-25-000011.md) | [27.3](/filings/0001941536-25-000011.md) | [(12.8) d](/filings/0001941536-26-000005.md) | [(15.5)](/filings/0001941536-26-000025.md) | [0.3](/filings/0001941536-26-000025.md) | [34.5](/filings/0001941536-25-000011.md) | [(15.1) d](/filings/0001941536-26-000005.md) | [(31.3)](/filings/0001941536-26-000025.md) | [(0.5)](/filings/0001941536-26-000025.md) |
| Diluted EPS | $ per share | [0.22](/filings/0001628280-24-047665.md) | not reported | [(0.55)](/filings/0001628280-25-024290.md) | [(0.33)](/filings/0001941536-25-000006.md) | [0.31](/filings/0001941536-25-000011.md) | not reported | [(0.41)](/filings/0001941536-26-000010.md) | [(0.12)](/filings/0001941536-26-000025.md) | [0.37](/filings/0001941536-25-000011.md) | not reported | [(0.69)](/filings/0001941536-26-000010.md) | [(0.13)](/filings/0001941536-26-000025.md) |
| Basic EPS | $ per share | [0.25](/filings/0001628280-24-047665.md) | not reported | [(0.55)](/filings/0001628280-25-024290.md) | [(0.33)](/filings/0001941536-25-000006.md) | [0.39](/filings/0001941536-25-000011.md) | not reported | [(0.41)](/filings/0001941536-26-000010.md) | [(0.12)](/filings/0001941536-26-000025.md) | [0.50](/filings/0001941536-25-000011.md) | not reported | [(0.69)](/filings/0001941536-26-000010.md) | [(0.13)](/filings/0001941536-26-000025.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.4](/filings/0001628280-24-047665.md) | [23.0](/filings/0001628280-25-012821.md) | [6.8](/filings/0001628280-25-024290.md) | [8.5](/filings/0001941536-25-000006.md) | [33.3](/filings/0001941536-25-000011.md) | [39.3](/filings/0001941536-26-000005.md) | [22.3](/filings/0001941536-26-000010.md) | [17.0](/filings/0001941536-26-000025.md) | [55.1](/filings/0001941536-25-000011.md) | [31.4](/filings/0001941536-26-000025.md) | [9.0](/filings/0001941536-26-000010.md) | [7.2](/filings/0001941536-26-000025.md) |
| Current assets | $m | [63.8](/filings/0001941536-23-000013.md) | [45.2](/filings/0001628280-25-012821.md) | [25.2](/filings/0001628280-24-031789.md) | [38.9](/filings/0001628280-24-036974.md) | [74.3](/filings/0001628280-24-047665.md) | [63.8](/filings/0001941536-26-000005.md) | [46.4](/filings/0001628280-25-024290.md) | [53.6](/filings/0001941536-25-000006.md) | [88.2](/filings/0001941536-25-000011.md) | [40.2](/filings/0001941536-26-000025.md) | [19.2](/filings/0001941536-26-000010.md) | [32.5](/filings/0001941536-26-000025.md) |
| Total assets | $m | [291](/filings/0001941536-23-000013.md) | [273](/filings/0001628280-25-012821.md) | [252](/filings/0001628280-24-031789.md) | [282](/filings/0001628280-24-036974.md) | [307](/filings/0001628280-24-047665.md) | [291](/filings/0001941536-26-000005.md) | [276](/filings/0001628280-25-024290.md) | [279](/filings/0001941536-25-000006.md) | [311](/filings/0001941536-25-000011.md) | [330](/filings/0001941536-26-000025.md) | [314](/filings/0001941536-26-000010.md) | [324](/filings/0001941536-26-000025.md) |
| Current liabilities | $m | [15.4](/filings/0001941536-23-000013.md) | [25.4](/filings/0001628280-25-012821.md) | [20.1](/filings/0001628280-24-031789.md) | [24.9](/filings/0001628280-24-036974.md) | [21.7](/filings/0001628280-24-047665.md) | [23.4](/filings/0001941536-26-000005.md) | [21.2](/filings/0001628280-25-024290.md) | [24.6](/filings/0001941536-25-000006.md) | [22.3](/filings/0001941536-25-000011.md) | [16.5](/filings/0001941536-26-000025.md) | [21.3](/filings/0001941536-26-000010.md) | [18.7](/filings/0001941536-26-000025.md) |
| Total liabilities | $m | [240](/filings/0001941536-23-000013.md) | [247](/filings/0001628280-25-012821.md) | [240](/filings/0001628280-24-031789.md) | [242](/filings/0001628280-24-036974.md) | [238](/filings/0001628280-24-047665.md) | [237](/filings/0001941536-26-000005.md) | [236](/filings/0001628280-25-024290.md) | [237](/filings/0001941536-25-000006.md) | [233](/filings/0001941536-25-000011.md) | [266](/filings/0001941536-26-000025.md) | [280](/filings/0001941536-26-000010.md) | [290](/filings/0001941536-26-000025.md) |
| Long-term debt | $m | [205](/filings/0001941536-23-000013.md) | [205](/filings/0001628280-25-012821.md) | [204](/filings/0001628280-24-031789.md) | [204](/filings/0001628280-24-036974.md) | [203](/filings/0001628280-24-047665.md) | [202](/filings/0001941536-26-000005.md) | [202](/filings/0001628280-25-024290.md) | [201](/filings/0001941536-25-000006.md) | [200](/filings/0001941536-25-000011.md) | [212](/filings/0001941536-26-000025.md) | [216](/filings/0001941536-26-000010.md) | [233](/filings/0001941536-26-000025.md) |
| Current portion of debt | $m | [1.9](/filings/0001941536-23-000013.md) | [2.1](/filings/0001628280-25-012821.md) | [2.0](/filings/0001628280-24-031789.md) | [2.1](/filings/0001628280-24-036974.md) | [2.1](/filings/0001628280-24-047665.md) | [2.2](/filings/0001941536-26-000005.md) | [2.2](/filings/0001628280-25-024290.md) | [2.5](/filings/0001941536-25-000006.md) | [2.6](/filings/0001941536-25-000011.md) | [0.9](/filings/0001941536-26-000025.md) | [2.9](/filings/0001941536-26-000010.md) | [2.8](/filings/0001941536-26-000025.md) |
| Shareholders' equity | $m | [(298)](/filings/0001628280-24-047665.md) | [(328)](/filings/0001941536-26-000005.md) | [(349)](/filings/0001941536-25-000011.md) | [(328)](/filings/0001941536-25-000011.md) | [(304)](/filings/0001941536-25-000011.md) | [(327)](/filings/0001941536-26-000025.md) | [(347)](/filings/0001941536-26-000025.md) | [(351)](/filings/0001941536-26-000025.md) | [(322)](/filings/0001941536-25-000011.md) | [(343)](/filings/0001941536-26-000025.md) | [(380)](/filings/0001941536-26-000025.md) | [(387)](/filings/0001941536-26-000025.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.0 d](/filings/0001628280-24-047665.md) | [14.7 d](/filings/0001628280-25-012821.md) | [(22.8)](/filings/0001628280-25-024290.md) | [(22.6)](/filings/0001628280-24-036974.md) | [0.2](/filings/0001628280-24-047665.md) | [12.2 d](/filings/0001941536-26-000005.md) | [(17.7)](/filings/0001941536-26-000010.md) | [1.4 d](/filings/0001941536-26-000025.md) | [41.0 d](/filings/0001941536-25-000011.md) | [(8.0) d](/filings/0001941536-26-000005.md) | [(21.1)](/filings/0001941536-26-000010.md) | [(15.7) d](/filings/0001941536-26-000025.md) |
| Capital expenditure | $m | [5.5 d](/filings/0001628280-24-047665.md) | [2.7 d](/filings/0001628280-25-012821.md) | [1.0](/filings/0001628280-25-024290.md) | [1.0 d](/filings/0001941536-25-000006.md) | [1.2 d](/filings/0001941536-25-000011.md) | [1.0 d](/filings/0001941536-26-000005.md) | [3.3](/filings/0001941536-26-000010.md) | [0.9 d](/filings/0001941536-26-000025.md) | [6.3 d](/filings/0001941536-25-000011.md) | [70.4 d](/filings/0001941536-26-000005.md) | [5.7](/filings/0001941536-26-000010.md) | [2.8 d](/filings/0001941536-26-000025.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.8](/filings/0001941536-23-000013.md) | [74.1](/filings/0001628280-24-031789.md) | [45.4](/filings/0001628280-24-036974.md) | [79.5](/filings/0001628280-24-047665.md) | [47.6](/filings/0001628280-25-024290.md) | [48.3](/filings/0001941536-25-000006.md) | [88.0](/filings/0001941536-25-000011.md) | [53.8](/filings/0001941536-26-000010.md) | [53.9](/filings/0001941536-26-000025.md) | [92.1](/filings/0001941536-25-000011.md) | [55.3](/filings/0001941536-26-000010.md) | [56.4](/filings/0001941536-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,826,140 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001941536-26-000025.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.